Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2025 04:17 ET | Source: Telix Pharmaceuticals Limited

Telix Reports US$186M Q1 Revenue, Up 62% YOY

Telix Pharmaceuticals reported strong Q1 2025 revenue of $186 million, up 62% year-on-year, driven by Illuccix® sales and RLS Radiopharmacies acquisition.